FDA Inspection
Amgen, Inc.Amgen, Inc. – FDA Inspection, Mar 16, 2018
Record Details
This FDA Inspection record concerns Amgen, Inc., with an inspection on March 16, 2018, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · d0e046ab-e62b-4cd7-94ba-97f0f5fc5292
Inspection Facts
- Inspection number
- 1046609
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Amgen, Inc.
29| Date | Classification | Office | Project area |
|---|---|---|---|
| August 7, 2025 | Not classified | Los Angeles District Office | |
| March 13, 2025 | VAI | Los Angeles District Office | Drug Quality Assurance |
| February 6, 2024 | Not classified | Los Angeles District Office | |
| September 14, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 13, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amgen, Inc.
- FDA Inspection 1278976 - 2025-08-07
- FDA Inspection 1256132 - 2025-03-13
- FDA Inspection 1240449 - 2024-02-06
- FDA Inspection 1220409 - 2023-09-14
- FDA Inspection 1112791 - 2019-12-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.